TransCure BioServices at the 11th International HBV Cure ANRS | MIE Workshop 2024: Advancing HBV Research and Collaboration
TransCure BioServices is proud to announce our participation in the 11th International HBV Cure ANRS | MIE Workshop, scheduled for July 03, 2024, at the prestigious Château Montchat in Lyon. This important event is organized by The Association Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS), a longstanding partner of ICE-HBV, and represents a crucial gathering for experts in the field of HBV research.
The ongoing challenges posed by hepatitis B virus (HBV) infection underscore the need for cutting-edge research and innovative therapeutic strategies. The International HBV Cure ANRS | MIE Workshop is dedicated to addressing these challenges by providing a platform for the latest scientific advancements, fostering collaboration among leading researchers, and facilitating the exchange of knowledge.
Join Ha-Yeon Kim-Penard, PhD, Scientist Business Developer, at this pivotal event to learn about our latest contributions to HBV research, including our advanced preclinical humanized liver mouse models. These models are essential for understanding HBV pathogenesis and testing new therapeutic approaches. Ha-Yeon is eager to engage with fellow researchers, explore potential collaborations, and discuss how our innovative solutions can support ongoing and future HBV research projects.
This workshop is a must-attend event for anyone involved in HBV research, offering a unique opportunity to advance your knowledge, showcase your research, and network with peers in the field. Participation is free of charge for all attendees, thanks to public funding from the French government.
Stay tuned for the official program announcement and further event details on the ANRS website. We look forward to meeting you in Lyon and working together towards the goal of curing HBV.
See you at the 11th International HBV Cure ANRS | MIE Workshop 2024!
Attending in person for TransCure bioServices:
Ha-Yeon Kim-Penard, PhD, Business Development
Ha-Yeon Kim-Penard holds a PhD in Cell and Molecular Biology from the University of Paris, in France. She worked at the Curie Institute (Orsay, France) in the field of cancer biology in cutaneous melanoma, before joining the TransCure bioServices Team as Project Leader in 2020. She has led many in vivo preclinical projects encompassing immuno-oncology, infectious diseases, inflammatory diseases in humanized Immune System and humanized liver mouse models.